APA (7th ed.) Citation

SB, K., V, G., H, K., VK, A., L, K., N, C., & D, K. (2026). Repurposing Imeglimin for Chemotherapy-Induced Cognitive Impairment: Targeting Mitochondrial Dysfunction and Neuroinflammation. Cellular and molecular neurobiology, 46(1), . https://doi.org/10.1007/s10571-026-01684-z

Chicago Style (17th ed.) Citation

SB, Kondaveeti, Gupta V, Kaur H, Arunprasad VK, Kapil L, Choudhary N, and Kumar D. "Repurposing Imeglimin for Chemotherapy-Induced Cognitive Impairment: Targeting Mitochondrial Dysfunction and Neuroinflammation." Cellular and Molecular Neurobiology 46, no. 1 (2026). https://doi.org/10.1007/s10571-026-01684-z.

MLA (9th ed.) Citation

SB, Kondaveeti, et al. "Repurposing Imeglimin for Chemotherapy-Induced Cognitive Impairment: Targeting Mitochondrial Dysfunction and Neuroinflammation." Cellular and Molecular Neurobiology, vol. 46, no. 1, 2026, https://doi.org/10.1007/s10571-026-01684-z.